The Myeloma Program at Huntsman Cancer Institute is known for its tandem transplant protocol, a treatment approach offered at very few medical centers around the country. Research demonstrates that the median survival rate with our treatment process is 10 years or more and that 80% of newly-diagnosed myeloma patients will achieve complete remission.
The Multiple Myeloma (MM) Program at Huntsman Cancer Institute is committed to providing comprehensive medical care using evidence-based medical treatments combined with excellent personalized care. With a team of highly trained scientists and clinicians, the MM Program continues to translate clinical research into new treatments for our patients.
|"Your excellent treatment for me has given hope to a lot of myeloma patients that it is possible to still be surviving after 9 years (and still counting). Thanks for everything you have done to extend my life. I sure am enjoying my time off of treatment."
–Becky R. of Florida
|For more information, or to schedule an appointment, call 801-587-4652|